BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26201623)

  • 21. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of the development of antibiotic resistance in Staphylococcus aureus.
    Schito GC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():3-8. PubMed ID: 16445718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
    de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
    World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The drug resistance of pathogenic bacteria of nosocomial infections in surgical intensive care unit].
    Chen J; Li LF; Guan XD; Chen DM; Chen MY; Ouyang B; Huang SW; Wu JF
    Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1189-92. PubMed ID: 17147864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
    Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
    Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
    Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ETIOLOGY AND RESISTANCE PROFILE OF ISOLATED STRAINS FROM SEVERE SYSTEMIC INFECTIONS IN PATIENTS WITH IMMUNODEPRESSION--EXPERIENCE OF THE IASI INFECTIOUS DISEASES HOSPITAL 2011-2014.
    Pleşca CE; Luca MC; Luca AS; Constantinescu S; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1141-6. PubMed ID: 26793861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of antibiotic-resistant infection in the newborn.
    Gray JW; Patel M
    Arch Dis Child Educ Pract Ed; 2011 Aug; 96(4):122-7. PubMed ID: 21586610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic resistance in patients with liver cirrhosis: Prevalence and current approach to tackle.
    Liakina V
    World J Clin Cases; 2023 Nov; 11(31):7530-7542. PubMed ID: 38078132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
    Eta S; Kawahara M
    Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns.
    Singh N; Gayowski T; Rihs JD; Wagener MM; Marino IR
    Liver Transpl; 2001 Jan; 7(1):22-6. PubMed ID: 11150417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial resistance to antimicrobial agents: an overview from Korea.
    Kim WJ; Park SC
    Yonsei Med J; 1998 Dec; 39(6):488-94. PubMed ID: 10097674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)].
    Cantón R; Ruiz-Garbajosa P
    Enferm Infecc Microbiol Clin; 2013 Oct; 31(8):543-51. PubMed ID: 24041416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.